Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05972070 · ClinicalTrials.gov registry record
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
A clinical trial of Heart Failure and Myocardial Infarction, sponsored by ROM Technologies.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05972070: Recruiting study of Heart Failure and Myocardial Infarction, sponsored by ROM Technologies.
NCT05972070 is a study of Heart Failure and Myocardial Infarction that is actively recruiting participants, run by ROM Technologies. The registered enrollment target is 500 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05972070, a study of Heart Failure and Myocardial Infarction, is actively recruiting participants, sponsored by ROM Technologies.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco cessation, lipid, blood pressure, and psychosocial management. These tasks will be accomplished through concurrent conversations between patients and their therapist's utilizing telemedicine with observed exercise training.
Primary Outcome
Measure the number of sessions attended to determine the ease of patients to utilize home-based cardiac rehab integrated with telemedicine (non-inferiority to historical controls)
Conditions Studied
Interventions
- DEVICE ROMTech Portable Connect
Study Locations (1)
Connecticut
- ROMTech - Brookfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-12-31 |
What NCT05972070 shows while recruiting
NCT05972070 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (76% lower).
The record links to 8 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which ROMTech Portable Connect is the first listed.
NCT05972070 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05972070 about?
NCT05972070 is a clinical study titled "Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence". The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco c...
What is the current status of trial NCT05972070?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-06-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05972070 study?
This clinical trial studies the following conditions: Heart Failure, Myocardial Infarction, Cardiac Rehabilitation, Valve Disease, Heart, Coronary Artery Bypass.
What interventions are being tested in trial NCT05972070?
The interventions under investigation include: ROMTech Portable Connect (DEVICE).
Who is sponsoring clinical trial NCT05972070?
This trial is sponsored by ROM Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05972070 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05972070's enrollment target sits among peer trials
500 101st of 397 higher than 294 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI